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INTRODUCTION
Previous studies have reported that the main pathological
features in temporal lobe epilepsy (TLE) are Ammon’s horn
sclerosis (AHS) or hippocampal sclerosis (HS), neoplasia and
glioneuronal malformations (1, 2). Our neuropathologic stud-
ies with 202 TLE cases have demonstrated that the most com-
mon epileptogenic cause is AHS, however, most of the cases
presented the combination of AHS/HS and neuronal migra-
tion disorder (NMD) as a type of dual pathology (3). 
NMD lesions, including cortical dysplasia (CD) or micro-
dysgenesis, are caused by impeded normal neurogenesis and
migration of neurons during the fetal brain development (3,
4). Cortical dysplasia (CD) is a term to describe the histo-
pathologic changes in disorders of cerebral cortical develop-
ment, such as localized or diffuse cortical abnormality, lis-
sencephaly, agyria/pachygyria, polymicrogyria, schizencepha-
ly, and hemimegalencephaly (4, 5). Cortical malformations
are a broad category of congenital brain abnormalities caused
by altered development during the formation of the cerebral
cortex and are frequently epileptogenic (6, 7). Some of the
NMDs clearly have a genetic etiology, however, the etiology
is unknown in a large number of sporadic cases. While NMD
lesions are frequently found in neocortical epilepsies, the epi-
leptogenic mechanism is not sufficiently studied.
Animal models of NMD have been generated in rodents
by intrauterine exposure to methylazoxymethanol acetate
(MAM), ionizing radiation, or ethanol, and prenatal cortical
freezing (8-11). In the neocortex of NMD animals induced
by MAM and irradiation, there were characteristic histopatho-
logic features similar to those found in human NMD, and
epileptogenic susceptibility was increased (12, 13). 
A recent study has demonstrated that NMDAR2 subunit
protein is selectively expressed in the dysplastic neurons of
the human epileptic neocortex (14). Rapid excitatory signal
transduction is mediated by activating the postsynaptic glu-
tamate receptors (15). One subtype of which,  -amino-3-
hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors
transmit fast excitatory synaptic potentials, while another
subtype, N-methyl-D-aspartate (NMDA) receptors, which
have ligand-gated ion channels with voltage-dependent prop-
erties, mediate prolonged neuronal depolarization (16). The
present study was undertaken to investigate the correlation
of histopathologic changes and glutamate receptor abnormal-
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Upregulation of Glutamate Receptors in Rat Cerebral Cortex with
Neuronal Migration Disorders
Neuronal migration disorders (NMDs) constitute the main pathologic substrate of
medically intractable epilepsy in human. This study is designed to investigate the
changes in expression of glutamate receptor subtypes on radiation-induced NMD
in rats. The lesion was produced by intrauterine irradiation (240 cGy) on E17 rats,
and then 10 weeks old rats were used for the study. The pathologic and immuno-
histochemical findings for glutamate receptor subunit proteins on NMD cortex were
correlated with development of behavioral seizures and EEG abnormality. Sponta-
neous seizures uncommonly occurred in NMD rats (5%); however, clinical stages
of seizures were significantly increased in NMD rats by an administration of kainic
acid. Brains taken from irradiated rats revealed gross and histopathologic features
of NMD. Focal cortical dysplasia was identified by histopathology and immunohis-
tochemistry with neurofilament protein (NF-M/H). Significantly strong NR1 and
NR2A/B immunoreactivities were demonstrated in cytomegalic and heterotopic
neurons of NMD rats. The results of the present study indicate that epileptogene-
sis of NMD might be caused by upregulation of glutamate receptor expression in
dysplastic neurons of the rat cerebral cortex with NMDs.
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ities in an experimental NMD. 
MATERIALS AND METHODS
Experimental NMD in rats by irradiation
Wistar rats were housed and maintained according to the
animal care guide lines of the Research Institute of Medical
Science, Chonnam National University. Age-matched preg-
nant rats, 20 weeks old, were exposed to 240 cGy of exter-
nal radiography irradiation from a linear accelerator (Mevatron
7600, Siemens, U.S.A.) on gestational day 17 (E17). Gesta-
tional day 1 (E1) was counted when insemination was detect-
ed by vaginal smear. Newborn rats were obtained from the
irradiated mother rats, and they were maintained carefully.
Ten weeks old rats were used in this study. There were four
experimental groups consisting of control (n=10) and NMD
rats (n=30) for clinical, histopathological and immunohis-
tochemical study. 
Clinical and EEG monitoring
For the clinical observation of seizure development and
EEG monitoring, a stereotaxic operation was carried out from
control (n=5) and NMD rats (n=20). Nine weeks old rats
were anesthetized with intraperitoneal injection of sodium
phenobarbital (50 mg/kg), and fixed in an animal stereotaxic
frame (David Kopf, Tujunga, CA, U.S.A.). Bipolar electrodes
were placed in the left frontal cortex and hippocampus. Elec-
trodes were fixed on scalp with dental cement and connect-
ed to an electrode socket. The rats were let free for a week to
recover from the operation. For standard EEG recording, the
electrode socket were connected via freely moving interface
cables to an EEG monitor. Development of spontaneous seizure
or seizure induced by an intraperitoneal injection (1 mg/kg)
of kainic acid (KA, Nacalitesque, Kyoto, Japan) was moni-
tored continuously for 5 hr in each rat. The clinical seizures
were rated on 5 stages (17) with respect to gradual progres-
sion: (i) rhythmic mouth and facial twitching, (ii) head nod-
ding and wet-dog shakes, (iii) forelimb clonus, (iv) rearing,
and (v) loss of balance and falling.
Histopathology and immunohistochemistry
Ten weeks old rats, control (n=5) and NMD (n=10) groups,
were anesthetized with intraperitoneal injection of sodium
phenobarbital (50 mg/kg), and then they were perfused intra-
cardially with phosphate-buffered saline (PBS, pH 7.40).
The brains were removed, and fixed in buffered formalin for
48 hr. Serial coronal sections, 3 mm thick, were made from
the formalin-fixed brains, and gross abnormalites were des-
cribed. Then, the brain sections were embedded in paraffin,
and cut with a microtome into 6  m thick tissue sections. 
For histopathologic evaluation, the tissue sections were
stained with hematoxylin and eosin (H&E). Bielschowsky
silver stain and immunohistochemical stains for glial fibril-
lary acidic protein (GFAP, Dako, Glostrup, Denmark), neu-
rofilament protein (NF-M/M, Sternberger-Mannheim, Luther-
vill, MD, U.S.A.), microtubule-associated protein 2 (MAP2,
Boehringer-Mannheim, Germany), vimentin (Dako, Glostrup,
Denmark) were performed in selected cases. For the investi-
gation of glutamate receptor changes in human and experi-
mental rat NMDs, a series of antibodies for glutamate recep-
tor subunits (14, 18, 19) were used (Table 1). Tissue sections
from the control and NMD brains were collected on probe-
glass slides (Fisher Scientific, Pittsburg, PA, U.S.A.), and
processed for immunohistochemistry by avidin-biotin con-
jugation method (20). Tissue sections were incubated in 1.5%
H2O2 in phosphate buffered saline (PBS), treated in 10%
normal goat serum in PBS for 30 min in order to block char-
ged sites on the tissue surface, and then incubated with pri-
mary antibodies throughout overnight at 4℃. After treat-
ment with 1% avidin-biotinylated horseradish peroxidase
(Research Genetics, Huntsville, AL, U.S.A.) for 1 hr at room
temperature, the tissue sections were prepared for chromogen
reaction with 3-amino-9-ethyl carbazole (AEC, Biomedia,
Foster City, CA, U.S.A.). The sections were counter stained
with hematoxylin, and examined by a light microscope.
RESULTS
Clinical data 
Development of epileptic seizures and EEG abnormalities
in NMD and control rats were summarized in Table 2. Dur-
ing the clinical observation and EEG monitoring, only one
of 20 rats with NMD presented spontaneous seizures show-
ing staring, mouth and facial twitching, and salivation. How-
ever, 17 of 20 rats had seizures after an intraperitoneal KA
provocation. During behavioral seizures in NMD rats, the
EEG activity was characterized by abnormally amplified rhyth-
mic spike discharges initially developed from the left cortex
and then from the left hippocampus (Fig. 1A). In the behav-
ioral manifestations of seizures in NMD rats, 14 rats devel-
oped stage 5 seizures (orofacial twitching, wet-dog shakes,
forelimb clonus, rearing and falling), and 3 rats developed
stage 3 seizures (orofacial twitching, wet-dog shakes and fore-
Receptors Antibody Clone Source Type Dilution
NMDA NR1 54.1 PharMingen Mouse IgG2a 1:100
NR2A/B Polyclonal Chemicon Goat IgG 1:100
AMPA GluR2 1B5 Novocastra Mouse IgG2b 1:100
GluR3 Polyclonal Santa Cruz Goat IgG 1:100
Table 1. Primary antibodies for glutamate receptor subunit pro-
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limb clonus). Behavioral seizures occurred in NMD rats for
21.3±2.6 min during 5 hr period after the KA provoca-
tion, and each seizure lasted 10 to 56 sec (mean 27±6 sec).
Two NMD rats showed EEG abnormality without behavioral
seizure. In control groups, only one of 5 rats had seizures and
the other one showed a mild EEG abnormality after an intra-
peritoneal KA provocation. The behavioral manifestation of
seizures were staring and orofacial twitching (stage 1) in the
rat. The seizure occurred for 2.3 min during 2 hr after the
KA provocation, and each seizure lasted 5 to 13 sec (mean,
7±2 sec). The seizure spontaneously disappeared at 3 hr after
the KA provocation.
Pathologic features
Coronal sections of the brain in control group showed well
defined gray and white matter of the cerebral cortex, and
intact corpus callosum. NMD group that had been irradiat-
Fig. 1. Pathophysiologic features in a rat with neuronal migration disorder (NMD). EEG from an NMD rat with kainic acid provocation (1
mg/kg, ip) shows abnormal rhythmic spikes initially developed from the cortex, and then from the hippocampus (A). Comparing with con-
trol cortex (AL-116), coronal section of the irradiation-induced NMD brain (AL-119) disclose microcephaly, markedly thinned neocortex,
agenesis of corpus callosum, and blurring of the gray and white matter junction (B). Histopathologic features of NMD reveal increased
immunoreactivities for neurofilament protein (NF-M/H) in a focal area of the gray matter (C, ×10), and abnormally oriented cytomegalic
neurons (D, ×120).
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ed on E17 consistently showed microcephaly, agenesis of cor-
pus callosum, thinning of the gray matter of cerebral cortex,
and ill-defined border of the gray and white matter (Fig. 1B).
The affected cortex had nearly one half the thickness of com-
parable cortex in controls. Cystic changes or hydrocephalus
was not noted.
Histologically, control brains showed 4 layers of the gray
matter consisting of I, II/III/IV, V/VI layers of human-equiva-
lent, and cortical subplate layer. The laminations were rela-
tively well identified on ×40 magnification field by light
microscopic examinations. In irradiated brains, histopatho-
logic features of NMD were noted. NMD in the experimen-
tal animals was characterized by loss of normal lamination of
the gray matter, neuronal heterotopia in the layer I and white
matter, and presence of cytomegalic neurons. Nodular clusters
of normal-sized cytomegalic neurons were seen in the layer I
and subpial surface. Neurons were dyslaminated randomly
throughout the gray matter of the neocotex. Nodular clusters
of cytomegalic neurons in the cortex were noted in seven ani-
mals, and the lesion was more clearly identified by immuno-
Fig. 2. Immunohistochemistry for glutamate receptor subunit proteins in the control and NMD cortex. Control cortex shows diffuse and
moderate expression of NR1 in the neurons throughout the gray matter (A, ×40), and discrete expression of GluR3 in some large pyra-
midal neurons of the deep gray matter (B, ×40). NMD cortex discloses significantly increased expression of NR1 (C, ×100), NR2A/B (D,
×100), and GluR2 (E, ×100) in subpial heterotopic neurons and cytomegalic neurons.
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Ahistochemical stain for neurofilament protein (Fig. 1C). Cyto-
megalic neurons usually have thickened or abnormally aboriz-
ing dendrites, and some of them are abnormally oriented
(Fig. 1D). Balloon cells found in some human NMD and
cortical tubers were not be identified. In the hippocampi,
focal disruption of pyramidal neurons in corpus ammonis
with neuronal ectopia were seen in six animals. The lesions
are developed at area CA1 and CA2 in 4 rats, CA2 and CA3
in 2 rats.
Immunohistochemical data for glutamate receptor subunits
Immunohistochemical expressions of glutamate receptor
subunits in the control and NMD cortex are summarized in
Table 3. In the control cortex, neurons in layer II/III/IV were
diffusely and moderately immunoreactive to NR1 (Fig. 2A)
and GluR2, and negative immunoreaction to NR2A/B and
GluR2. Neurons in layer V/VI were moderately immunore-
active to NR1 and GluR3 (Fig. 2B), and mildly immunore-
active to NR2A/B and GluR2. NR2A/B presented finely
granular or dot-like immunoreactivity in the neuronal cyto-
plasm. GluR3 immunoreactivity was limited in a few large
pyramidal neurons in layer V/VI. Neurons in cortical sub-
plate were mildly immunoreactive to NR1.
In NMD cortex, immunoreactivity for glutamate receptor
subunits were demonstrated (Fig. 2C-E). Heterotopic neu-
rons in the layer I and white matter, cytomegalic neurons,
and normal-sized dysplastic neurons had strong immunore-
activity to NR1 (Fig. 2C), NR2A/B (Fig. 2D), and GluR2
(Fig. 2E). NR1 and GluR2 were labeled in neuronal cyto-
plasm and proximal portion of dendrites. NR2A/B showed
coarsely granular immunoreactivity in dysplastic neurons.
Abnormal neurons in NMD cortex were mildly immunore-
active to GluR3.
DISCUSSION
The experimental cerebral cortical malformation produced
by an intrauterine irradiation was initially studied in an at-
tempt to understand cortical development (21, 22). The pre-
sent study demonstrated that the intrauterine irradiation pro-
duced NMD pathology in rats, which in turn, resulted in an
increased seizure susceptibility. In this experiment, pregnant
rats were exposed to 240 cGy of external irradiation from a
linear accelerator on gestational day 17 (E17). Different radia-
tion sources have been used; however, the malformative lesions
were similar (10). Radiation dosages in most studies ranged
from 150 to 250 cGy. 
In the present study, spontaneous clinical seizures associat-
ed with epileptiform EEG activity was observed in only one
out of 20 NMD rats (5%). However, most of NMD rats (90%)
developed clinical seizures after small dose of KA provoca-
tion. Clinical stage, duration, and frequency of seizures were
significantly increased in NMD rats than controls. These clini-
cal data suggested that NMD might cause epileptic seizures
by way of an intrinsic epileptogenecity or decreasing the
threshold to excitatory neurotransmitter-induced seizures.
Experimental and clinical studies suggest that NMD could
increase seizure susceptibility (3, 23, 24). In particular, in
vivo animal studies using an experimental model of NMD
showed a decreased seizure threshold to kainic acid and to
hyperthermia in the immature brain (23, 25). In vitro stud-
ies using the same experimental model suggested increased
epileptiform discharges in brain tissue with experimentally
induced NMD (26). 
Brains from adult animals that have been irradiated on E16
or E17 show five major gross and microscopic abnormalities
consisting of microcephaly, diffuse cortical dysplasia, neuronal
heterotopia, focal areas of ectopic neurons in the hippocam-
pus, and agenesis or severe hypoplasia of the corpus callosum
(22, 25). Cortical dysplasia in these animals is characterized
by loss of normal lamination of the neocortex, random distri-
bution of large pyramidal cells, and nodular neuronal hetero-
topia. According to a pathologic grading of NMD in human
(3), NMD is graded as four-layered polymicrogyria or micro-
dysgenesis (grade I), presence of small or normal-sized dys-
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1 2-4 5&6 CxS
Cortical layers of control group
NMD cortex
NR1 - ++ ++ + +++
NR2A/B --+* - +++
GluR2 - ++ + - ++/+++
GluR3 -- ++
� - +/++
-; negative, +; mild, ++; moderate, +++; strong immunoreactivity, CxS;
cortical subplate, NMD; neuronal migration disorder.
*; granular or dot-like immunoreactivity, 
� ; limited in a few large pyrami-
dal neurons.
Table 3. Immunohistochemical findings of glutamate receptor
subunits in the control and NMD rats
Control rats NMD rats
(n=5) (n=20)
Spontaneous seizure 0 1
Stage 1* (1)
Seizure after KA
� 11 7
Stage 1* (1)
Stage 2
Stage 3 (3)
Stage 4
Stage 5 (14)
Duration of total seizures (min)
� 2.3 21.3±3.6
Duration of each seizure (sec)
� 7±22 7 ±6
EEG abnormality without behavioral seizure 1 2
No EEG abnormality 3 0
*Clinical stage of seizure (see reference 21). 
� intraperitoneal injection
of kainic acid (1 mg/kg). 
� Duration of total seizures and each seizure
were checked for 5 hr after kainic acid provocation.
Table 2. Clinical features of control and radiation-induced NMD
ratsplastic neurons with normal or loss of lamination (grade II),
cytomegalic neurons (grade III), and balloon cells (grade IV).
The grading of NMD rats in the present study falls in the
grade III of human NMD. 
In the present study, brains from 10 weeks old rats with
irradiation on E17 also show gross and microscopic abnor-
malities. Nodular clusters of neurons in layer I up to the pial
surface and the periventricular white matter are commonly
seen. Focal cortical dysplasia, which is similar to grade III of
NMD in human, is consistently observed in the neocortex.
The focal lesion is hardly identified by gross examination,
but relatively well defined by light microscopic examinations
of routine H&E, or silver-stained tissue slides. Immunohis-
tochemical stains for neurofilament proteins and MAP2 are
helpful to find abnormally dense stained lesion of focal cor-
tical dysplasia. The focal lesion is easily identified on ×2-
×40 magnification field of light microscope. Cytomegalic
or normal-sized neurons bearing abnormal neurofilament
proteins in their cytoplasm and dendrites are frequently dis-
oriented. Balloon cells are not noted in these animals.
Recent studies have demonstrated that NMDAR plays an
important role in hyperexcitability associated with human
or some animal models of human epilepsy (27, 28). Using
the recently developed antibodies for glutamate receptor sub-
unit proteins, immunohistochemical expression of NMDAR
were studied in human cortical dysplasia, and increased immu-
noreactivities for NR1 (splice variants of NR1-1a, -1b, -2a,
and -2b) and NR2A/B subunit proteins were found in resect-
ed human dysplastic cortex (14, 29-32). The immunoreac-
tivity was localized to dysplastic neurons or cells that appear
disordered compared with the normal laminar structure of
cortex (14, 29). Both dysplastic neurons and nondysplastic
neurons were immunoreactive to AMPA GluR2/3, but denser
immunoreactivity was observed in dysplastic neurons (14).
Theses reports suggest that hyperexcitability of dysplastic
cortical regions possibly caused by increased expression of
NR2 subunits and NR1 splice variants in dysplastic neurons.
In the present study, cerebral cortex associated NMD showed
significantly increased expression of NR2A/B subunit pro-
teins by immunohistochemistry, while control cortex showed
positive reaction in a few large pyramidal neurons in the deep
gray matter (layer V/VI of human cortex). NR1, GluR2,
and GluR3 showed slightly increased immunoreactivities
in NMD cortex than control. These results strongly suggest
that NMDA receptors composed of both NR1 and NR2A/B
are also increased in the NMD lesions of experimental rats.
The intracellular mechanisms by which NR2A/B increases
in the abnormal neurons of NMD are still unknown. NMD
results from disturbances of normal development of cerebral
cortex, which consists of neuroblast proliferation, neuronal
migration and differentiation, and manifests in an aberrant
synaptic connection, and an altered regulation of intracyto-
plasmic organelles (30, 33, 34). These abnormalities could
lead to increased NR2A/B receptor proteins in abnormal neu-
rons of NMD. Therefore, abnormalities in neurotransmitter
and receptor, and aberrant synapses might be explained the
epileptogenic mechanism of NMD.
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